Cargando…

Continued use of azithromycin for mild COVID-19 in India: Evidence and implications?

Azithromycin is an antibiotic commonly used for treating respiratory, gastrointestinal infections besides enteric fever, otitis media etc. It's convenient short duration oral dosing regimens and good tolerability make it a popular drug in routine outpatient settings in primary to tertiary care....

Descripción completa

Detalles Bibliográficos
Autores principales:	Atal, Shubham, Misra, Saurav, Balakrishnan, Sadasivam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884298/ https://www.ncbi.nlm.nih.gov/pubmed/35280614 http://dx.doi.org/10.4103/jfmpc.jfmpc_812_21

Ejemplares similares

Implications and Economic Impact of Applying International Guidelines and Recommendations to the Management of High-Risk Group of Type 2 Diabetes Mellitus Patients in India
por: Fatima, Zeenat, et al.
Publicado: (2022)

Approval of Itolizumab for COVID-19: A Premature Decision or Need of The Hour?
por: Atal, Shubham, et al.
Publicado: (2020)

Diabetes care during COVID-19 lockdown at a tertiary care centre in India
por: Joshi, Rajnish, et al.
Publicado: (2020)

The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19
por: Sadasivam, Balakrishnan, et al.
Publicado: (2020)

Understanding the molecular–pharmaceutical basis of sartan recalls focusing on valsartan
por: Ray, Avik, et al.
Publicado: (2020)

A pilot point prevalence study of antimicrobial drugs in indoor patients of a teaching hospital in Central India
por: Najmi, Ahmad, et al.
Publicado: (2019)

Medication concordance in modern medicine – A critical appraisal from an Indian perspective
por: Atal, Shubham, et al.
Publicado: (2019)

Early onset gestational diabetes mellitus: A case report and importance of early screening
por: Najmi, Ahmad, et al.
Publicado: (2019)

Tigecycline-Induced Severe Hypoglycemia in a Non-Diabetic Individual: A Case Report and Brief Review of Tigecycline-Induced Severe Hypoglycemia
por: Ray, Avik, et al.
Publicado: (2020)

Azithromycin for mild-to-moderate COVID-19
por: Patel, Jigar, et al.
Publicado: (2021)

Organoids: An invaluable tool in pharmacology
por: Balakrishnan, Sadasivam, et al.
Publicado: (2020)

Pattern of Disease and Therapy for Diabetes along with Impact of Generic Prescribing on Cost of Treatment among Outpatients at a Tertiary Care Facility
por: Atal, Shubham, et al.
Publicado: (2021)

Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin
por: Million, Matthieu, et al.
Publicado: (2021)

Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome
por: Okour, Malek, et al.
Publicado: (2020)

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
por: Cavalcanti, Alexandre B., et al.
Publicado: (2020)

Azithromycin for mild-to-moderate COVID-19 – Authors' reply
por: Hinks, Timothy S C
Publicado: (2021)

A Novel Metric System to Quantify Antibiotic Consumption in Paediatric Population: A Hospital Based, Biphasic Pilot Study
por: Ahmed, Shah Newaz, et al.
Publicado: (2020)

Telephonic Triage in Times of COVID-19: Experiences at a Telemedicine Center in India
por: Ray, Avik, et al.
Publicado: (2021)

COVID-19 appropriate behavior in India: Time to invest for the benefits in future
por: Gupta, Manoj Kumar, et al.
Publicado: (2021)

Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19
por: Lamback, Elisa Baranski, et al.
Publicado: (2021)

Azithromycin: can its benefit be ruled out in mild COVID-19?
por: Rodríguez-Molinero, Alejandro
Publicado: (2021)

Pneumococcal disease in India: The dilemma continues
por: Mathew, Joseph L., et al.
Publicado: (2014)

Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy
por: Scherrmann, JM.
Publicado: (2020)

Evidence-Based Health Policies and Its Discontents – Comparative Global and Indian Perspectives with a Focus on the COVID-19 Pandemic
por: Basu, Saurav
Publicado: (2021)

Mass azithromycin administration: considerations in an increasingly resistant world
por: Hooda, Yogesh, et al.
Publicado: (2020)

Use of handheld infrared thermometers in COVID-19 pandemic for mass screening: Understanding its implications through a case report
por: Najmi, Ahmad, et al.
Publicado: (2020)

Inpatient use of mobile continuous telemetry for COVID-19 patients treated with hydroxychloroquine and azithromycin
por: Gabriels, James, et al.
Publicado: (2020)

IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?
por: Atal, Shubham, et al.
Publicado: (2020)

Rationale for azithromycin in COVID-19: an overview of existing evidence
por: Gyselinck, Iwein, et al.
Publicado: (2021)

Antibody responses in mild COVID-19 hospital staff
por: Plebani, Mario
Publicado: (2020)

COVID-19 and informal settlements – implications for water, sanitation and health in India and Indonesia
por: Parikh, Priti, et al.
Publicado: (2020)

medical education and training: implications for india
por: Anand, Akshay, et al.
Publicado: (2014)

medical education and training: implications for india
por: Anand, Akshay, et al.
Publicado: (2013)

Approaches to critical care resource allocation and triage during the COVID-19 pandemic: an examination from a developing world perspective
por: Basu, Saurav
Publicado: (2021)

Home versus institutional isolation of mild COVID-19 patients
por: Christopher, Devasahayam Jesudas, et al.
Publicado: (2021)

The current situation of COVID-19 in India
por: Jabaris S, Sugin Lal, et al.
Publicado: (2021)

Immunological response after mild COVID-19: How long will it last?
por: Balduzzi, Adriana
Publicado: (2021)

Commentary: Rapid assessment of avoidable blindness and diabetic retinopathy in India
por: Misra, Neha, et al.
Publicado: (2020)

Azithromycin Should Not Be Used to Treat COVID-19
por: Lighter, Jennifer, et al.
Publicado: (2020)

Use of glucocorticoids and azithromycin in the therapy of COVID-19
por: de Lemos Neto, Miguel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dub6lisu1nmpqnsnnjiuvpuami